Wang Y, Ma C H, Qiao J
Center for Reproductive Medicine, Peking University Third Hospital, Beijing 100191, China.
Zhonghua Fu Chan Ke Za Zhi. 2016 Jun 25;51(6):436-41. doi: 10.3760/cma.j.issn.0529-567X.2016.06.007.
To predict the genes that affect endometrial receptivity through the differential expression of microRNA (miRNA) in eutopic endometrial tissues during implantation window in patients with endometriosis infertility.
Among infertile patients that received treatments at the Center for Reproductive Medicine, Peking University Third Hospital between May and December 2013, patients with endometriosis infertility were selected as endometriosis group (among the selected 17 cases, there were 6 cases with follicular phase endometrium and 11 cases with implantation window phase endometrium), and patients with tubal factor infertility were selected as control group (among the selected 19 cases, there were 7 cases with follicular phase endometrium and 12 cases with implantation window phase endometrium). (1)Implantation window phase endometrium was selected from 3 cases in each group. Using miRNA and mRNA joint gene sequencing and database for forecast results, as well as using the negative regulatory relationship between miRNA and mRNA, the intersection of target gene that negatively correlates with miRNA expression were obtained. The co-expression network of miRNA-mRNA wae constructed. Combined with the genes associated with endometrial receptivity found through bioinformatics method, the miRNA with core regulatory functionwas found. (2) Expand sample size to 14 cases for endometriosis group and 16 cases for control group.Reverse transcription (RT)-PCR technique was utilized to detect the expression of miR- 142- 5p, miR- 146a- 5p and miR- 543 in endometrial tissues, and verify miRNA microarray results.
(1) miRNA and mRNA microarray screening results showed that, among the endometrial tissues of patients with endometriosis infertility and with implantation window phase, 6 differentially expressed miRNA were indentified, among which miR-142-5p, miR-146a-5p, miR-1281, miR-940, miR-4634 showed significantly enhanced expression and miR- 543 showed significantly inhibited expression. Sixty- three differentially expressed mRNA were indentified, among which 58 mRNA such as CADM1, IL-10RA, ITGAL and LPAR5 had significantly enhanced expression. Five mRNA such as HLA- DRB1,3,4,5 and SOHLH2 showed significantly inhibited expression. Thirty- six taget genes were found in consideration of negatively correlated miRNA expression with the genes, miRNA-mRNA co-expression network were constructed. The miR-543 was found at the core of the network. Targetscan and other database predicted that miR-142-5p, miR- 146a- 5p and miR- 543 could act on various types of endometrial receptivity molecular corresponding marker genes such as HOX10, ITGAV, ITGB3, OPN, LIF, ESR, PGR, CDH1 and MMP. (2) RT- PCR test showed that the average levels of expression of miR-142-5p and miR-146a-5p in implantation window phase endometrium in endometriosis group were 8.3±10.6 and 1.9±0.8 respectively; the average levels of that in control group were 1.1±0.6 and 0.9±0.4, respectively. The difference was statistically significant (P=0.027, P=0.015), and was consistent with results from miRNA microarray test. The expression of miR-543 in tissues of follicular phase endometrium in endometriosis group (2.3±1.0) was significantly higher than that in control group (1.0 ± 0.4), and the difference was statistically significant (P=0.008). However, when comparing the expression of miR-543 implantation window phase endometrium in endometriosis group (1.2±0.6) with that in control group (1.5±1.0), the difference was not statistical significant (P=0.890).
There are multiple differential expressions of miRNA in the implantation window phase endometrium tissues of endometriosis infertility patients, among which miR-142-5p and miR-146a-5p show significantly enhanced expression and may affect embryo implantation by acting on a variety of endometrial receptivity marker molecules. The expression of miR- 543 in implantation window phase endometrium of endometriosis infertility patients is lower than that in the follicular phase, forewarned changes in the pattern of cyclic variation of miR-543, and may be the reason for affecting endometrial receptivity.
通过子宫内膜异位症不孕患者种植窗期在位内膜组织中微小RNA(miRNA)的差异表达,预测影响子宫内膜容受性的基因。
选取2013年5月至12月在北京大学第三医院生殖医学中心接受治疗的不孕患者,将子宫内膜异位症不孕患者作为子宫内膜异位症组(入选的17例中,卵泡期内膜6例,种植窗期内膜11例),输卵管因素不孕患者作为对照组(入选的19例中,卵泡期内膜7例,种植窗期内膜12例)。(1)每组选取3例种植窗期内膜,采用miRNA与mRNA联合基因测序及数据库预测结果,并利用miRNA与mRNA的负调控关系,获得与miRNA表达呈负相关的靶基因交集,构建miRNA-mRNA共表达网络。结合通过生物信息学方法发现的与子宫内膜容受性相关的基因,找出具有核心调控功能的miRNA。(2)将子宫内膜异位症组样本量扩大至14例,对照组扩大至16例。采用逆转录(RT)-PCR技术检测内膜组织中miR-142-5p、miR-146a-5p和miR-543的表达,验证miRNA芯片结果。
(1)miRNA与mRNA芯片筛选结果显示,在子宫内膜异位症不孕患者种植窗期内膜组织中,共鉴定出6个差异表达的miRNA,其中miR-142-5p、miR-146a-5p、miR-1281、miR-940、miR-4634表达显著增强,miR-543表达显著抑制。共鉴定出63个差异表达的mRNA,其中CADM1、IL-10RA、ITGAL和LPAR5等58个mRNA表达显著增强,HLA-DRB1、3、4、5和SOHLH2等5个mRNA表达显著抑制。考虑到与miRNA表达呈负相关的基因,共发现36个靶基因,构建了miRNA-mRNA共表达网络,发现miR-543处于网络核心。Targetscan等数据库预测miR-142-5p、miR-146a-5p和miR-543可作用于多种子宫内膜容受性分子相应标记基因,如HOX10、ITGAV、ITGB3、OPN、LIF、ESR、PGR、CDH1和MMP。(2)RT-PCR检测显示,子宫内膜异位症组种植窗期内膜中miR-142-5p和miR-146a-5p的平均表达水平分别为8.3±10.6和1.9±0.8;对照组分别为1.1±0.6和0.9±0.4,差异有统计学意义(P=0.027,P=0.015),与miRNA芯片检测结果一致。子宫内膜异位症组卵泡期内膜组织中miR-543的表达(2.3±1.0)显著高于对照组(1.0±0.4),差异有统计学意义(P=0.008)。然而,比较子宫内膜异位症组种植窗期内膜中miR-543的表达(1.2±0.6)与对照组(1.5±1.0),差异无统计学意义(P=0.890)。
子宫内膜异位症不孕患者种植窗期内膜组织中存在多个miRNA差异表达,其中miR-142-5p和miR-146a-5p表达显著增强,可能通过作用于多种子宫内膜容受性标记分子影响胚胎着床。子宫内膜异位症不孕患者种植窗期内膜中miR-543的表达低于卵泡期,提示miR-543的周期性变化模式发生改变,可能是影响子宫内膜容受性的原因。